MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.700
+0.010 (0.37%)
At close: Jun 27, 2025, 4:00 PM
2.840
+0.140 (5.19%)
After-hours: Jun 27, 2025, 5:52 PM EDT
MEI Pharma Market Cap
MEI Pharma has a market cap or net worth of $17.99 million as of June 27, 2025. Its market cap has decreased by -3.80% in one year.
Market Cap
17.99M
Enterprise Value
-2.48M
1-Year Change
-3.80%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since December 31, 2003, MEI Pharma's market cap has decreased from $670.20M to $17.99M, a decrease of -97.32%. That is a compound annual growth rate of -15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 18.70M | 14.02% |
| Dec 31, 2024 | 16.40M | -57.51% |
| Dec 29, 2023 | 38.60M | 18.77% |
| Dec 30, 2022 | 32.50M | -89.20% |
| Dec 31, 2021 | 301.00M | 1.31% |
| Dec 31, 2020 | 297.10M | 62.62% |
| Dec 31, 2019 | 182.70M | -2.72% |
| Dec 31, 2018 | 187.80M | 141.70% |
| Dec 29, 2017 | 77.70M | 46.60% |
| Dec 30, 2016 | 53.00M | -2.93% |
| Dec 31, 2015 | 54.60M | -40.85% |
| Dec 31, 2014 | 92.30M | -46.40% |
| Dec 31, 2013 | 172.20M | 580.63% |
| Dec 31, 2012 | 25.30M | 105.69% |
| Dec 30, 2011 | 12.30M | 73.24% |
| Dec 31, 2010 | 7.10M | -86.19% |
| Dec 31, 2009 | 51.40M | - |
| Dec 31, 2008 | 51.40M | -74.17% |
| Dec 31, 2007 | 199.00M | 2.58% |
| Dec 29, 2006 | 194.00M | -45.49% |
| Dec 30, 2005 | 355.90M | -30.12% |
| Dec 31, 2004 | 509.30M | -24.01% |
| Dec 31, 2003 | 670.20M | - |
View and export this data all the way back to 2003.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |